SII to produce additional 100 million Covid-19 vaccine doses
Serum Institute of India (SII) has expanded its alliance with Gavi and the Bill &...
EU, UK bodies urge medicine prioritisation in Brexit trade talks
The Association of the British Pharmaceutical Industry (ABPI) and European Federation of Pharmaceutical Industries and...
AbbVie gets orphan drug and fast track status for elezanumab
AbbVie has received orphan drug and fast track designations from the US Food and Drug...
Ena Respiratory’s nasal spray shows promise against Covid-19
Australian biotech company Ena Respiratory has said that its nasal spray has significantly mitigated Covid-19...
GSK’s Nucala receives FDA approval to treat HES
The US Food and Drug Administration (FDA) has granted approval for GlaxoSmithKline (GSK)’s Nucala (mepolizumab)...
Indivior lays out restructuring plans to cut down expenses
UK-based pharmaceutical firm Indivior has stated that it is restructuring the organisational and financial locus...
Gilead and Eisai obtain Japanese approval for RA drug Jyseleca
Gilead Sciences and Eisai have received approval from the Japanese Ministry of Health, Labour and...
RDIF and ChemRar agree to supply Avifavir to 17 countries
The Russian Direct Investment Fund (RDIF) and ChemRar Group will be supplying a Covid-19 drug,...
FDA grants priority review for Pfizer’s Xalkori in paediatric ALCL
Pfizer has secured priority review from the US Food and Drug Administration (FDA) for Xalkori...
